A Year to Remember: The Biggest European Biotech News in 2020
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
The UK Supreme Court has supported an appeal by British biotech Kymab to revoke antibody…
Update (04/06/2020): After upholding four of Kymab's patents addressing the production of antibody drugs earlier…
As the 2017 reports roll in, we're already turning our gaze to 2018. These are…
Kymab has published positive results in Science Translational Medicine for a new antibody with the…
We interviewed David Chiswell, a pioneer in the development of therapeutic antibodies and now the…
Cambridge's image is tied to its Hogwarts-like University and Nobel-hoarding academia, but there's also an…
Looking forward to 2016, I wondered which Biotechs I would watch closely. Here's my list…
Monday: A report said that the total value of crowdfunded Biotech projects from within the EU…
Kymab is the European biotech to watch! Based in Cambridge (UK), the company has developed the Kymouse…